You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Generics
11 January 2021 - - An independent Data and Safety Monitoring Board has reviewed the safety data from the phase 2 clinical trial of the Sputnik V vaccine and recommended the phase 3 recruitment and co...
8 January 2021 - - US-based Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application, from the US Food and Drug Admin...
4 January 2021 - - An international collaboration of physicians has just published an updated protocol for early at-home treatment of COVID-19, which recognizes the three stages of the disea...
30 December 2020 - EpiVax Inc, a US-based biotechnology company, has revealed an update on the progress of its peptide therapeutic immunogenicity assessment programme, it was reported on Tuesday.The p...
29 December 2020 - Public health agency the US Food and Drug Administration announced on Monday that it authorised the first generic of glucagon for injection USP in 1 mg/vial in an emergency kit for ...
29 December 2020 - Peak Pharma Commercial Partners, a United States-based investment fund that deals with the acquisition and growth of branded, generic and over-the-counter pharmaceutical products, h...
Related Headlines
Hikma launches FDA approved generic Advair Diskus
Amring gains global rights to LYSTEDA
Troy Medicare Closes USD 10m Series B Led by AXA Venture Partners
Breckenridge wins final FDA approval for Pomalidomide Capsules ANDA
Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%